119 HR 8339
Drug Origin Transparency Act of 2026
Latest Action
Referred to the House Committee on Energy and Commerce.
2026-04-16
Read the Bill
Primary sources on Congress.gov:
Cosponsors (showing 3 of 3)
R · Crenshaw, Dan (Texas)D · Schrier, Kim (Washington)R · Hinson, Ashley (Iowa)Markets vs Bill
No directly-mapped prediction markets indexed yet for this bill's policy domain.
Cite this page
APA
Apprised.news. (n.d.). 119 HR 8339: Drug Origin Transparency Act of 2026. Retrieved 2026-05-13, from https://apprised.news/bill/119hr8339
MLA
"119 HR 8339: Drug Origin Transparency Act of 2026." Apprised.news. Web. 2026-05-13. <https://apprised.news/bill/119hr8339>.
Chicago
"119 HR 8339: Drug Origin Transparency Act of 2026." Apprised.news. Accessed 2026-05-13. https://apprised.news/bill/119hr8339.
BibTeX
@misc{apprised_119_hr_8339_drug_origin_transparency_act,
title = {119 HR 8339: Drug Origin Transparency Act of 2026},
publisher = {Apprised.news},
url = {https://apprised.news/bill/119hr8339},
note = {Accessed 2026-05-13}
}